Invivyd Announces That The New England Journal Of Medicine Has Published A Peer-reviewed Letter To The Editor Describing The Pemgarda (Pemivibart) Immunobridging Emergency Use Authorization Pathway, As Well As An Updated Correlate Of Protection Curve For